Tag: Adaptimmune Therapeutics competitors

news-05082024-200726

Analyst Ratings Update: Adaptimmune Therapeutics (NASDAQ: ADAP)

Adaptimmune Therapeutics, a clinical-stage biopharmaceutical company, has recently garnered the attention of analysts, with a mix of bullish and bearish sentiments. In the past...